Hi Guest Login
Home > Oncotype Dx Dcis Test > Ghaziabad
MAX@Home offers the Oncotype DX DCIS Test, a specialised genomic test that helps doctors evaluate the risk of recurrence in patients diagnosed with DCIS (Ductal Carcinoma In Situ). This test supports better-informed decisions about the need for radiation therapy after surgery.
The Oncotype Dx DCIS (ductal carcinoma in situ) test is a genomic test for early-stage breast cancer to predict its recurrence risk, helping doctors decide which treatment therapy can be given post-surgery based on individual needs and condition.
Eligibility check: Our healthcare team carefully reviews the patient's medical history and condition before the DCIS test.
Sample Collection: A tumor tissue sample is collected from the respective MAX Labs or hospital, where it is stored.
Genomic Analysis: The sample is analysed at our laboratory using advanced genomic technologies
Test Report Generation: A detailed report with the DCIS score is generated and shared with the treating doctor to guide further treatment decisions.
Doctor Discussion: Based on your DCIS score, your doctor will discuss the most appropriate treatment plan and guide you at every stage of your care.
Comfort: MAX@Home provides tumor sample pickup directly from the hospital or lab, eliminating the need for travel and ensuring a stress-free experience.
Doctor-Guided Care: Our oncologists coordinate throughout the entire treatment process to support accurate, personalized treatment decisions.
Trusted and Clinically Proven Test: The Oncotype DX DCIS Test is globally recognised and trusted by oncologists for accurate breast cancer treatment planning.
Ghaziabad Coverage: Our Oncotype Dx DCIS test services are available across Ghaziabad , ensuring timely and reliable support wherever you are.
The DCIS score, which ranges from 0 to 100, predicts a 10-year risk of cancer recurrence (DCIS or invasive cancer) in the same breast following breast-conserving surgery.
DCIS Score Interpretation Table:
|
DCIS Score Range |
Risk Level |
What It Means |
How It Helps in Treatment Decisions |
|
0 – 38 |
Low Risk |
Low chance of cancer returning in the same breast within 10 years after surgery |
Radiation therapy may not be necessary; the doctor may suggest monitoring or hormonal therapy |
|
39–54 |
Intermediate Risk |
Moderate chance of DCIS or invasive cancer recurrence |
The doctor will assess whether radiation therapy may provide benefit based on individual factors |
|
55–100 |
High Risk |
Higher chance of cancer returning in the same breast |
Radiation therapy is more likely to be recommended to reduce the recurrence risk |
Key notes:
NOTE: Your oncologist will interpret the score in conjunction with age, tumor size, and pathology information to determine the best treatment plan.
MAX@Home offers advanced Oncotype DX DCIS testing, including tissue sample collection and expert oncologist support, across Ghaziabad .
Schedule your Oncotype DX DCIS test today, or call us now to speak with our care team for more details
Read More